Gunderson Dettmer represented client TCG Crossover, a life sciences-focused investment firm, in the formation of its $1 billion TCG Crossover Fund II. TCG Crossover is dedicated to advancing disruptive medicines and supporting companies that can improve the lives of patients. The firm invests in both public and private companies led by exceptional entrepreneurs focused on developing better treatment options for patients.

In the announcement of the fund formation, TCG Crossover founder Dr. Chen Yu said, “On behalf of the TCGX team, we are proud to have exceeded our target for the Fund II raise and we are pleased with the returns we have delivered for our limited partners during a challenging market.”

The Gunderson Dettmer team consisted of Andrew Thornborrow, Andrew Fink, Ben Buckwalter, Lily Kim, Amanda Chan, Sasha Benincasa, Luke Charette and Ally Eagan.

Companies 
TCG Crossover